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The purpose of this study was to examine the associations between daytime and nighttime 
ambulatory blood pressure (ABP) on carotid IMT when controlling for daytime physical activity 
(PA) in a sample of 201 healthy older adults (mean age 66.9 yrs, 49.8% females) who were part 
of the 6 year follow-up of the Pittsburgh Healthy Heart Project (PHHP).  D aytime ABP and 
nighttime ABP were assessed every 45 minutes over a period of 3 days and 2 nights.  Physical 
activity was measured by a wrist accelerometer, a waist accelerometer, and a self-report measure 
of physical activity. Regression analysis was used to analyze the association of daytime and 
nighttime ABP with carotid IMT and to determine the type of PA measure (wrist, waist, or self-
report), and the time interval (1, 5, 10, 15 m inutes prior to ABP) that has the greatest influence 
on daytime ABP.  Results showed that PA 1 minute (wrist) and 10 minutes (waist) prior to ABP 
assessment accounted for 9% of the variance in daytime ABP. When entered separately into a 
regression model, both daytime SBP (F(1,194)=6.33, p=.01) and nighttime SBP (F(1,194)=6.46, 
p=.01) significantly predicted IMT.  When entered simultaneously into the model, both daytime 
SBP(F(1,193)=1.81, p=.18) and nighttime SBP(F(1,193)=1.94, p=.17) lost their significance. 
However, after adjusting for PA, daytime SBP (F(1,193)=3.47, p=.06) was a marginally stronger 
predictor of IMT than nighttime SBP. This finding supports the specific prognostic importance 
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of daytime ABP and, to that extent, may support work on a greater understanding of the daytime 
variables that uniquely influence daytime ABP as potential correlates of CVD risk. 
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1.0  SPECIFIC AIMS 
 Numerous studies have shown that 24 hour ambulatory blood pressure (ABP) is a better 
predictor of cardiovascular morbidity and mortality than clinic blood pressure measured in the 
doctor’s office.  There is still debate, however, on the relative importance of daytime and 
nighttime ABP in the prediction of cardiovascular endpoints.  When daytime and nighttime ABP 
are examined separately, each has been found to be significantly associated with cardiovascular 
disease.  However, when the two predictors are examined together in the same statistical models, 
the majority of studies have found that nighttime ABP remains significant whereas daytime ABP 
does not.  The explanation for the superior prognostic value of nighttime ABP is unclear, but a 
number of factors may play a role.   
It is frequently noted that ABP measures collected during daytime hours may be affected 
by a number of confounding influences that are less prevalent at night, making the daytime 
measures less precise, and thereby, less predictive.  One important factor that may affect daytime 
BP is daytime physical activity.  Engaging in physical activity leads to an acute increase in 
systolic BP and the greater the intensity of the physical activity, the greater the increase in BP.  
However, these fluctuations due to acute physical activity are not harmful to physical health, 
unlike other sources that elevate BP.  It is possible that the association between ABP and CVD is 
attenuated by the effects of physical activity, and this attenuation may be greatest when daytime 
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ABP is assessed.  None of the existing studies examining the relative prognostic value of 
daytime and nighttime ABP have controlled for physical activity.  This study will be the first to 
examine the predictive value of daytime versus nighttime BP when controlling for the effects of 
concurrent physical activity.  
The sample involves a group of 296 older adults (ages 56-76) from the Pittsburgh 
Healthy Heart Project 6 year follow up, in whom ABP was monitored in conjunction with 
multiple assessments of physical activity. To measure physical activity concurrently with 
ambulatory blood pressure assessments, waist and wrist actigraphy was used, as well as a self-
report physical activity diary. Carotid artery intima medial thickness (IMT), a marker of 
atherosclerosis, was measured to assess cardiovascular disease risk.  
Specific Aim 1: To compare the association between nocturnal ABP and daytime ABP with 
carotid artery IMT.   
As shown in previous studies, it is hypothesized that nocturnal BP will be more closely 
associated with IMT than daytime ABP when not controlling for physical activity. 
Specific Aim 2: To examine the effect of concurrent physical activity on daytime ABP. 
Previous studies have found that physical activity is one of the major determinants of daytime 
BP variation. Therefore, it is hypothesized that concurrent physical activity, as measured by 
actigraphy, will have a significant impact on daytime ABP. 
Specific Aim 3: To examine the association between daytime ABP and carotid IMT when 
controlling for concurrent daytime physical activity. 
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It is hypothesized that controlling for concurrent physical activity may strengthen the association 
between daytime ABP and IMT.  Controlling for physical activity may provide a more accurate 
marker of the relative pathogenic effects associated with daytime and nighttime ABP. 
Specific Aim 4: To compare nocturnal ABP and daytime ABP with carotid IMT when 
controlling for concurrent daytime physical activity.  
 Daytime physical activity may weaken the association between daytime ABP and CVD, which 
may partially account for the superior prognostic value of nighttime ABP over daytime ABP.  
Therefore, it is hypothesized that the pattern of associations between daytime and nighttime ABP 
with carotid artery IMT outlined in Specific Aim 1 will be altered when controlling for 
concurrent daytime physical activity, with daytime ABP now accounting for a larger independent 
portion of the variance.  
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2.0  BACKGROUND AND SIGNIFICANCE 
ABP is a Better Predictor of Cardiovascular Outcomes than CBP 
 There is a large literature examining the predictive value of ambulatory blood pressure 
(ABP) with respect to cardiovascular morbidity and mortality (1,2 ). The majority of the studies 
in this area have been prospective studies that examine both clinic blood pressure taken in the 
doctor’s office (CBP) and 24 hour ABP, with average follow up periods that range from 5 to 20 
years (1).  These studies have found CBP and ABP to be only moderately correlated, and of the 
two, ABP measures have generally been shown to be more strongly associated with 
cardiovascular outcomes, such as myocardial infarction, stroke, chronic coronary heart disease, 
and heart failure (1-17).  Tables 1 and 2 (pgs. 12-13) summarize the literature in this topic from 
the last 10 years, with the 9 most recent prospective studies from independent populations (8-17).  
Using multivariate Cox regression models, 7 out of the 9 studies found that ABP was a 
significant predictor of cardiovascular mortality and morbidity, while CBP lost its significance 
when both ABP and CBP were entered simultaneously into the same statistical model.  These 
most recent studies are consistent with the literature as a whole (1). 
In addition to the examination of cardiovascular morbidity and mortality, a growing body 
of literature has examined the relationship between 24 hour ABP and measures of subclinical 
cardiovascular disease such as carotid artery intima-medial thickness (IMT) (18-24). Carotid 
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IMT is a widely used index of cardiovascular risk, assessing the thickness of vascular lining, due 
to inflammation, vascular hypertrophy, and plaque, measured non-invasively by external 
ultrasound; carotid IMT has been shown to better predict the risk of myocardial infarctions and 
stroke than most other CVD risk factors (19).  Examining carotid IMT allows us to assess a 
significant marker of atherosclerosis in a continuous manner within a community sample (19). 
 There have been 7 studies published since the year 2000, all cross-sectional, that have 
examined the association of carotid IMT with both ABP and CBP.  Tables 3 and 4 (pgs. 13-14) 
describe these studies (18-24).  Four out of the 7 studies used multivariate regression models that 
included both CBP and ABP in their analyses (18, 21-23) and 2 of the studies entered CBP and 
ABP into separate regression models (19, 24).  Five of 7 studies found ABP to be significantly 
associated with carotid IMT, while CBP was not (18-19, 21, 23-24), and one study found that 
associations involving ABP (p<.0001) were non-significantly larger than those involving CBP 
(p<.01) (22).  Nystrom et al. was the only study to find that carotid IMT was equally correlated 
with CBP and ABP, however, this study did not compare CBP with ABP in the same statistical 
model (20).  In general, it appears that ABP outperforms CBP as a correlate of subclinical 
disease as well as clinical outcomes. 
 The majority of the research using ABP assessments has focused on average 
measurements taken over a 24 hour period.  There has been increasing interest, however, in the 
circadian variation in ABP, and there is emerging evidence that daytime and nighttime ABP may 
differ in prognostic significance for cardiovascular mortality and morbidity (25).  
Nighttime ABP is better than Daytime ABP as a Predictor of Cardiovascular Disease. 
 Fourteen prospective studies from independent populations published since 2000 
have compared daytime and nighttime blood pressure with cardiovascular risk.  Detailed 
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descriptions of these studies are displayed in Tables 5 and 6 ( pgs. 14-17) (8, 11-16, 25-29, 31, 
32). Out of these 14 studies, 10 found that nighttime ABP was a better predictor of 
cardiovascular disease than daytime ABP. Eight of these 10 entered both daytime and nighttime 
ABP simultaneously into a multivariate Cox regression model, and found that nighttime ABP 
was a significant predictor of cardiovascular outcomes, while daytime ABP lost its significance 
(11, 12, 13, 15, 25, 27, 29, 31).  Two of the remaining studies also examined daytime and 
nighttime ABP similarly (entered together into a multivariate model), and found that nighttime 
ABP was more strongly associated with cardiovascular events than daytime ABP.  In these 
studies, daytime ABP still remained a significant predictor, though it had either a smaller hazard 
ratio (14) or was not predictive of as many cardiovascular outcomes as nighttime ABP (32). 
The final 4 studies found that the independent prognostic value of daytime or nighttime 
ABP depended on the population (16) or cardiovascular outcome examined (28).  Eguchi et al. 
found that nighttime ABP was a better predictor of cardiovascular disease in non-diabetic 
hypertensives, but daytime ABP was a better in hypertensives with type 2 diabetes (16).  Metoki 
et al. found that both nighttime and daytime ABP were predictive, but for different 
cardiovascular outcomes (28). 
Pickering et al. and Hansen et al. found daytime systolic ABP to be a better predictor of 
cardiovascular disease when both daytime and nighttime systolic ABP were entered together into 
the same regression model, however, nighttime ABP (p<.0001) appeared to be a stronger 
predictor of stroke than daytime ABP (p=.0002) (26), and nighttime diastolic ABP (p=.021) 
appeared to be a stronger predictor of cardiovascular mortality than daytime diastolic CBP 
(p=.05) (8). 
In conclusion, the majority of the literature examining the prognostic value of daytime 
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and nighttime ABP supports the superiority of nighttime ABP over daytime ABP in predicting 
cardiovascular outcomes.  Possible explanations for the differences in relative predictive value of 
nighttime and daytime ABP as a function of population (for example, the finding that daytime 
ABP may be a relatively strong predictor among diabetics) may be due to characteristics of the 
population (in the case of diabetics, a higher body mass index (BMI) and a more sedentary 
lifestyle) that may reduce variance in daytime physical activity and thereby enhance its 
predictive value (16). 
The Apparent Superiority of Nighttime ABP Extends to Measures of Subclinical Disease 
   There have been 7 cross-sectional studies, to our knowledge, that have examined 
the association of nighttime ABP and carotid IMT: three of these compared daytime and 
nighttime ABP as predictors (33-34, 36), while the remaining 4 studies examined only the 
association of carotid IMT with nocturnal BP, or nocturnal BP dipping (35, 37-39).  Nocturnal 
dipping refers to the extent of decline of BP during the nighttime hours.  Studies have generally 
considered a nocturnal decline in BP of 10% or more to be normal (40).  Individuals who show 
this pattern are categorized as "dippers".  "Nondippers" are the individuals whose nighttime BP 
fall is attenuated or absent (40).  Table 7 and 8 (pgs. 17-18) summarize the findings of these 
studies.  The 3 studies that examined nighttime ABP found that it was more closely associated 
with carotid IMT than daytime ABP (33-34, 36), and the four studies that examined nocturnal 
BP dipping found that participants who lacked a dipping pattern had higher carotid IMT values 
(35, 37-39).  
One of the most recent studies in this group, Shintani et al.(33), examined the association 
of carotid IMT with daytime and nighttime BP in 775 participants from the Japanese general 
population with a mean age of 66 years.  This study found that a nocturnal decline in BP was 
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significantly and negatively correlated with mean IMT, such that those showing larger nocturnal 
declines had smaller IMT.  When both daytime and nighttime systolic BP were entered together 
into a multiple regression model, only nighttime BP was significantly associated with mean IMT 
(33).  The investigators suggest that nighttime ABP is more closely associated with target organ 
damage and prognosis than daytime ABP, though the reasons for this are still unclear. 
 According to the literature, there appears to be evidence that 24 hour ABP is superior to 
CBP in predicting cardiovascular endpoints, as well as measures of subclinical cardiovascular 
disease such as carotid IMT.  In addition, nighttime ABP appears to carry additional predictive 
value over daytime ABP for measures of both clinical and subclinical CVD. The reasons for the 
superior prognostic value of nighttime ABP remain uncertain. 
Reasons for Prognostic Value of Nocturnal ABP are Unknown 
 Several physiological mechanisms have been proposed that may be responsible 
for the superior prognostic value of nocturnal ABP (40-45).   Mechanisms such as changes in the 
sympathetic nervous system modulation of blood pressure at night, circadian changes in 
natriuresis, or the presence of sleep apnea, have been proposed as plausible sources of individual 
differences in nocturnal blood pressure that may be independent of BP as assessed during the day 
(40-45).  Studies have, in fact, found elevated nocturnal ABP to be associated with increased 
nighttime activity of the sympathetic nervous system, as assessed by day and nighttime levels of 
urinary catecholamines (42) or muscle sympathetic nerve activity (MSNA; 43).   In addition, 
Lurbe et al. reported a relationship between insulin resistance, determined by the homeostatic 
model assessment technique and elevated nocturnal, but not daytime, ABP in overweight and 
obese adolescents (45).  
 In addition to these physiological mechanisms, it has also been suggested that 
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confounding variables may play a role in accounting for the apparent superior prognostic value 
of ABP in the studies that have shown such effects.  It has been noted that daytime ABP is 
affected by a number of confounding influences that are not prevalent at night, which may make 
daytime ABP less precise as a marker of cardiovascular risk (29). For example, a few studies 
found that daytime ABP lost its prognostic significance when examined in participants who were 
taking anti-hypertensive medications (27, 30), although the results of other studies did not find 
evidence to support the effect of anti-hypertensive medication on the prognostic significance of 
daytime ABP. (8, 10). Because daytime BP is usually the target for treatment, antihypertensive 
drugs might be presumed to have a larger impact on daytime ABP than on nighttime ABP. 
 One possibly major confound noted by investigators is daytime physical activity (27, 29-
31, 50).  Several investigators suggest that nighttime BP is more stable than the daytime ABP 
because of variations in physical activity during the day, which may attenuate the association 
between daytime ABP and cardiovascular disease (27, 29-31). However, none of these reports 
were equipped to test this hypothesis. 
Physical Activity is Associated With ABP 
 Several studies have examined the effect of physical activity on 24 hour ABP, but 
to our knowledge, only six have done so using accelerometry, which is, arguably, the most 
accurate widely used measure of physical activity in an ambulatory study (46-49). Many studies 
have compared the use of self-report measures of physical activity and accelerometers against 
doubly labeled water and indirect calorimetry, the current standard in physical activity 
measurement, and have found that accelerometers are more accurate in estimating energy 
expenditure (52-56). In addition, a few of these studies have found that waist accelerometers tend 
to be more accurate then wrist accelerometers due to the failure of wrist accelerometers to detect 
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trunk movements (55, 56). It has been suggested that the combination of both a wrist and waist 
accelerometer may provide a better overall estimate of physical activity (53, 56). In these 6 
studies described below, physical activity was measured by a wrist actigraph (46, 49, 51), waist 
actigraph (47), an acceleration pickup sensor on the ABP instrument (50), and accelerometers 
mounted on the trunk and legs (48). 
 Several studies used within-subject correlations to identify the time interval over which 
physical activity most strongly influences within-person fluctuations in blood pressure 
measurements.    Leary et al. and Jones et al. found that average activity in the 15 minutes 
preceding ABP was most strongly associated with ABP values while the remaining three studies 
found that shorter time intervals of 6 minutes (47), 5 minutes (51), and 3 minutes (49, 50) had 
the most influence over ABP. All six of these studies found that physical activity was associated 
with ABP (p<.05), although variance in ABP explained by physical activity differed among 
studies as well as within individuals (46-49).  For example, Leary et al. found that the percentage 
variance in ABP explained by physical activity ranged from 7.1% to 10.7% between individuals 
and it ranged from 0% to 62% in within-subjects analyses (46).  Hayashi et al. compared non-
adjusted SBP levels with physical activity-adjusted SBP levels between subjects during three 
levels of physical activity in daily life: resting, walking, vigorous exercise.  This study found that 
if an individual engages in walking-level physical activity, SBP may increase by about 
10mmHG, and during vigorous exercise, SBP may increase by about 20mmHG (50).   O’Shea 
and Murphy examined ABP variation within subjects on a more active day and a less active day 
(52 activity units vs. 35 activity units p<.0001), where they were asked to reduce their level of 
physical activity.  The results showed that subjects had a significantly higher systolic ABP 
during their active day then on their less active day (136mm HG vs. 130mm HG, p<.005) (51). 
10
These results provide support for the hypothesis that individuals who are physically active may 
show significantly higher daytime ABP than sedentary individuals 
 All these studies found that physical activity significantly affects ABP, though this effect 
appears to vary within and between individuals (46-51).  However, none of these studies have 
examined how adjusting for physical activity may affect the relationship between daytime ABP 
and cardiovascular outcomes.   
The Potential Role of Physical Activity in Confounding the Comparisons Between Daytime 
and Nighttime ABP Remains Unknown 
 In the literature that has compared the prognostic value of ABP versus CBP, 
nearly all of the studies have found ABP to be superior in predicting cardiovascular disease. 
When comparing daytime and nighttime ABP, the majority of the studies have found nighttime 
ABP to be a better independent predictor of cardiovascular mortality and morbidity, while 
daytime ABP lost its prognostic significance when nighttime ABP was added into the same 
statistical model.   
The reasons for the superior prognostic value of nighttime ABP are uncertain. 
Measurement issues rather than physiological mechanisms may contribute insofar as daytime 
ABP is affected by several confounding influences, particularly daytime physical activity, that 
are not as apparent during the night. Indeed, several studies have found that physical activity, 
measured by actigraphy, is associated with fluctuations with daytime ABP, although it appears to 
vary between individuals. Without adjusting for physical activity, physically active individuals 
may show higher daytime ABP levels due to these exercise-induced fluctuations.  This may 
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attenuate the relationship between daytime ABP and cardiovascular disease since exercise has 
been associated with a decreased risk of hypertension and cardiovascular disease.   
There have been no studies to our knowledge that have examined the relationship 
between daytime ABP and cardiovascular disease, when adjusting for daytime physical activity. 
In addition, many of the studies that examined the association of physical activity and ABP only 
measured physical activity with a wrist actigraph, which by itself, is not the most accurate 
measure of physical activity.  This will be the first study, to our knowledge, to examine the 
relative association of daytime and nighttime ABP with measures of cardiovascular disease after 
taking into account the influence of daytime physical activity on daytime ABP.  The sample used 
in the proposed study is from a general population which, as evidenced by the existing literature, 
has shown nighttime ABP to carry greater prognostic value over daytime ABP in predicting 
cardiovascular disease.   
Study results will have implications for the relative emphasis placed on determinants of 
daytime and nighttime ABP in future research.  If nighttime ABP is still a stronger correlate of 
carotid IMT, even after adjustment for daytime physical activity, then relatively greater emphasis 
is warranted on understanding the biological and behavioral mechanisms that may directly affect 
nighttime ABP, and increased efforts are justified to lower nighttime ABP, such as taking anti-
hypertensive medication toward the evening hours rather than after waking.  However, if 
daytime ABP is more closely associated with carotid IMT after adjusting for physical activity, 
then greater emphasis should be placed on understanding the daytime variables that uniquely 
influence daytime ABP such as daily psychosocial stress, as potential correlates of 
cardiovascular risk.   
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3.0  METHODS 
The data for this project were derived from the 6-year follow-up from the Pittsburgh 
Healthy Heart Project (PHHP), which was designed to examine the role of biobehavioral factors 
in atherosclerotic progression in a healthy community sample. The protocol used for the 6 year 
follow up was ideal for answering the questions posed in this proposal because it implemented 
the use of a wrist and waist based accelerometer to measure physical activity, collected 3 days 
and 2 nights of 24 ABPM,  and examined measures of carotid IMT.   
Participants 
The PHHP study included 464 participants at baseline; all subjects met the following 
inclusion criteria: 50-70 years of age, no chronic disease, including coronary heart disease or 
hypertension, no cardiac medication including antihypertensive or lipid-lowering medication, no 
alcoholism, greater than eighth grade reading skill, and not employed in a position involving 
heavy labor (with potential to disrupt the operation of ambulatory blood pressure monitoring).    
A total of 296 participants gave consent to participate in the 6 year follow-up of PHHP. Out of 
those 296 participants, 27 chose not to complete the ambulatory monitoring assessments, but 
were allowed to continue in the study (296 – 27).  Out of these 269, 6 participants had data that 
was unusable due to problems with data retrieval (269 – 6).  Out of these 263, 36 participants did 
not have complete activity data. To be included in this study, participants were required to have 
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at least 2 full days of both actical and actiwatch data. Out of these 36, 7 did not have any actical 
data, 16 did not have actiwatch data, and 13 participants had less than two full days of either 
actical or actiwatch data. After excluding participants with missing activity data (263 – 36), this 
left the sample at 227 participants. 
The daytime period was determined by the participant’s first and last interaction with the 
electronic diary (ED).  The nighttime period was measured by examining the actiwatch data to 
determine when participants went to sleep and when they woke up.  Twenty one participants had 
unusable actiwatch data, with no apparent drop in activity during the night.  For these 
individuals, we implemented a conservative method to assess nighttime ABP by using fixed 
nighttime intervals from 1am – 5 am.   
 Participants were required to have at least five ABP measurements over the period of 
two nights.  Twenty-six participants did not meet this criterion, leaving 201 participants with 
valid data for these analysis (227 – 26).  Eight participants had only one full night of data, but 
otherwise met all the criteria described above; the rest of the sample had two nights of data. 
Recruitment Procedures 
The original PHHP study involved follow-up through 3 years only.  Participants had to be re-
contacted and re-consented in order to be included at the 6 year point. Contact with participants 
was maintained with participants via annual participant newsletters which assisted in keeping 
track of participant address changes as well as maintaining interest in the project among 
volunteer participants.  Participants were sent postage paid response postcards on which they 
indicated their interest in the follow-up, and were also given the opportunity to opt out of further 
contact.  If participants did not respond, they were sent repeated mailings (up to 3 separate 
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letters).  Non-responding participants were then called using the phone numbers listed in the 3 
year contact information.  Out of the 361 participants who participated in the 3 year follow-up, 
40 were non-responsive (i.e., lost to follow up), 6 were not interested the 6 year study, 8 did not 
respond to scheduling attempts after initial contact, and 1 was deceased, which left a total sample 
size of 296 participants for the 6 year follow-up. 
Procedures 
The 6 year follow up for PHHP involved 6 visits over a 3 month period. 
First Visit: The first visit consisted of a medical history interview followed by several 
physiological assessments (CBP, blood glucose, insulin, C-reactive protein, etc.) Subjects also 
completed questionnaires about their health habits. 
Second Visit:  The second visit was scheduled for a week later, and it was at this visit that 
subjects participated in a training session on the use of the ABPM, wrist and waist actigraph, and 
the ED that assessed various ambulatory behavioral states, including physical activity. Typically, 
this visit was scheduled on a Monday.  After this visit, participants were sent out for a practice 
monitoring day. 
Third Visit: Participants returned the following day, (usually Tuesday), to address any problems 
they may have encountered using the equipment.  After the third visit, the subjects were 
instructed to use the ABPM, ED, and both the wrist and waist actigraphs over the course of the 
next three days. They were also instructed to use the ABPM during the day and during two non-
consecutive nights of sleep (Wednesday and Friday nights). Following each ABP reading, 
participants were asked to report their physical activity in the 10 minutes prior to the cuff 
inflation, using a four point activity scale (1=limited activity – 4= heavy activity) presented by 
the ED. 
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Fourth Visit: The fourth visit occurred a week after the second visit (typically Monday). 
Participants returned to the lab and received feedback on the use of the ABPM, ED, and both 
actigraphs.  
Fifth Visit: The fifth visit occurred a week after the fourth visit and was scheduled at the 
Ultrasound Research Laboratory (URL). During this visit, carotid IMT and observable plaque 
was measured using ultrasound. 
Sixth Visit: The final visit occurred a week after the fifth visit and involved the measurement of 
heart rate variability and baroreceptor functioning, during two brief relaxation tasks. (data not 
used here). 
 
The figure below summarizes the sequence of visits for a typical participant: 
Week 1   Week 2 (Monday)  Week 2 (Tuesday)     Week 3 (Monday)  Week 4 
 
Visit 1   Visit 2     Visit 3       Visit 4   Visit 5 
CBP   Training session  Begin monitoring  Return Equipment  Carotid   
Medical History  (ABP, ED,      Feedback   IMT 
   Actigraphs) 
    
 
   Training period  Monitoring period 
        
      (3 days, 2 nights) 
Figure 1: Sequence of visits    
 
Due to participant availability, this typical schedule wasn’t always followed, but as long as 
participants completed all of their 6 visits within the 3 month period (as stated in the Institutional 
Review Board protocol), they were allowed to continue in the study. 
Measurements 
Electronic Diary (ED)  
The ED system was implemented on a personal digital assistant (PDA) device (Palm Pilot).  
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Diary items assessed ambulatory behavioral states (stressors, current mood, social interactions, 
physical activity) 10 minutes prior to cuff inflation.  Participants powered down the ED when 
they went to sleep, and turned it back on when they awoke the following day.  Immediately 
thereafter, the ED presented a set of questions about sleep timing and quality the previous night. 
Ambulatory Blood Pressure Monitoring (ABPM) 
 ABP measures were assessed over a three day testing period using the Accutracker DX 
ambulatory monitor, an ausculatory monitor, which is relatively quiet and comfortable for 
extended wear, and has been shown to track blood pressure changes appropriately during 
physical exercise and mental stress (57).  Participants had their BP measured at 45 minute 
intervals throughout the monitoring period.  Daytime ABP was defined from the time of 
awakening on each day to bed-time the following night, defined by participants’ first and last 
interaction with the ED.  Nighttime ABP was defined from the time of sleep onset until the time 
of awakening, as assessed by the actiwatch (see below).  We excluded ABP readings that were 
outside of estimated physiological ranges, using criteria established by Verdecchia et al. (58) 
(SBP  > 260 or < 70 mm Hg and DBP readings of > 150 or < 40 mm Hg). 
Physical Activity Measures 
Self-report Physical Activity 
 Self-report physical activity was measured after each ABP assessment, using the 
following ED item (Movement: which refers to participants’ level of PA in the 10 minutes prior 
to ABP assessment).  Response options ranged from 1 – 4 where: 1=limited movement (write), 
2=light movement (walk), 3=moderate movement (jog), 4=heavy movement (run). 
Actical 
 Accelerometry is a well validated method for objective assessment of physical activity in 
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free living environments and has been shown to be moderately to highly correlated with 
concurrent objective measures of energy expenditure, such as doubly labled water and indirect 
calorimetry (59).  The actical (Mini-mitter, Bend, Oregon) is an omnidirectional sensor which is 
worn at the waist on a belt; a pieza-electric sensor generates a voltage whenever there is a change 
in acceleration, signaling vertical movements of the torso.  The device records the frequency of 
motor movements for each minute, from which estimates of energy expenditure can be derived.  
Haile et al. developed regression algorithms that optimize the conversion between raw activity 
counts (AC) and activity energy expenditure (AEE, kcal×kg-1×min-1) as measured by indirect 
calorimetry (59). 
For lower counts (350 to 1200) that indicate sedentary activities such as sitting: 
AEE=0.0237 + (5.268E-5) × AC (R² = .75, SEE = 0.013, p<.001) 
For higher counts (≥ 1200) that indicate physical activity such as jogging: 
AEE=0.02663 + (1.107E-5) × AC(R² =.85, SEE = 0.015, p<.001) 
These parameters are calculated automatically by the actical unit. 
 Actiwatch 
 The actiwatch (Mini-mitter Inc., Bend, Oregon) is worn on the wrist and contains similar 
accelerometry sensors for detection of physical activity, though it is more sensitive to movement 
than the waist actigraph.  Participants wore the actiwatch throughout the 3 days and 2 nights 
during the monitoring period.  The actiwatch measures physical activity in 1 minute epochs, and 
gives an average count for each minute epoch.  The higher the activity counts, the higher the 
activity or movement.  It also can estimate when participants are sleeping.   
 Measures were collected across 3 days of ambulatory monitoring. Preliminary analyses 
have shown that all three physical activity measures (self-report, actiwatch, actical) may be 
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independent predictors of physical activity; they were used as additive measures of physical 
activity for this study; the effects of physical activity were operationalized as the total variance 
accounted for by all three measures.  
 In addition, the actiwatch was used to define sleep and wake times.  The device detects 
sleep onset and awakening using a wake threshold value (≤ 40 counts for a period of at least 10 
minutes). 
Carotid IMT 
 A Toshiba SSA-270A ultrasound scanner was used to identify the borders of the intima 
and medial layers of the left and right carotid arteries.  The distances between the intima-lumen 
interface and the media-adventitial interface were measured across the distal 1cm of the common 
carotid artery (near and far walls), the carotid bulb (far wall), and the first 1cm of the internal 
carotid (far wall).  Both right and left carotids were assessed, yielding a total of eight sets of 
images for measurement.  Mean carotid IMT was calculated for each subject using the mean 
interface distance from each of the eight segments and then averaging these measures across 
segments.   
Data Analysis  
 Based on results from previous literature (33) we would expect a small to medium effect 
size of .35.  Using a two-tailed test, an α level of .05, an effect size of .35, and a sample of 201 
participants, the power to detect effects of this magnitude is estimated at .79 (GPower). 
Specific Aims Testing 
Specific Aim 1: To compare the association between nighttime ABP and daytime ABP with 
carotid artery IMT. 
 Partial correlation analysis was used to examine the association between both daytime 
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and nighttime ABP with carotid IMT, while adjusting for standard covariates (age, sex, race) as 
well as any other variables that may significantly predict IMT.  Systolic and diastolic ABP were 
examined separately for both daytime and nighttime ABP. We tested for the difference between 
the daytime and nighttime correlation coefficients using the Test for Difference Between 
Dependent Correlations (60).  Similar to previous studies, we also conducted a multiple 
regression model to examine the independent influence of daytime and nighttime systolic and 
diastolic ABP measures, after covariate adjustment. 
Specific Aim 2: To examine the effect of concurrent physical activity on daytime ABP. 
 Multi-level modeling (Proc-Mixed) was used to examine within-person 
associations of daytime physical activity and ABP using all three measures of activity (wrist-
based, waist-based actigraphs, and self-report physical activity). Age, sex, and race were 
adjusted for in the model. Different time intervals of time-averaged activity (1, 5, 10, 15 min) 
prior to ABP measurement were examined to determine the time course of activity that is most 
closely associated with ABP.   All three measures of physical activity were added as independent 
predictors into the model. We also examined the optimal time intervals and PA measures for 
predicting ABP in between-subject analyses.  
Specific Aim 3: To examine the association between daytime ABP and carotid IMT when 
controlling for concurrent daytime physical activity. 
We took the mean daytime activity scores that were most strongly associated with daytime ABP 
for between-subject analyses and added them to a multiple regression analysis with mean SBP or 
DBP as the dependent variable.  The residuals from these models were then entered into a 
multiple regression model (along with our standard covariates) with carotid IMT as a dependent 
variable. 
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Specific Aim 4: To compare nocturnal ABP and daytime ABP with carotid IMT when 
controlling for concurrent daytime physical activity. 
 The Test for Difference Between Dependent Correlations (59) was conducted to test the 
statistical significance of the difference of the following two correlations: a) the partial 
correlation coefficient of the association of activity-adjusted daytime ABP and IMT (with 
standard covariates) and b) the partial correlation coefficient of the association of nighttime ABP 
and IMT (with standard covariates).  This was conducted separately for SBP and DBP.  We also 
conducted a multiple regression model to examine the independent influence of activity-adjusted 
daytime ABP and nighttime ABP with standard covariates, once again, separately for SBP and 
DBP. 
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                                                      4.0  RESULTS                                                                                   
Sample Characteristics 
Table 9 displays descriptive information regarding demographics and physical 
characteristics of the sample.  Half of the participants were women, and almost 88% of the 
sample was White.  Mean age was 66.95 years and mean BMI was 27.6.  Almost 29% of the 
sample reported currently taking anti-hypertensive medication.  We compared demographic 
variables between individuals who were currently taking hypertensive medication or clinically 
hypertensive (n=66) and those who were not, by t-test and chi-square analyses.  Hypertensive 
participants were significantly older (p=.04) and had a larger waist circumference (p=.03) than 
normotensive participants. (Table 10). 
A number of participants were excluded from this sample at the 6-year point on the basis 
of missing data, as noted above.  We examined whether these participants differed from those 
who were not excluded (see Table 11).  Participants who were excluded had significantly lower 
education status than those who were not (p=.005). Only 30% of excluded participants had at 
least a bachelor’s degree while nearly 58% of included participants had a bachelor’s degree or 
higher.  Participants who were excluded from the sample did not differ on any of the other 
demographic characteristics from those who were included in this sample. 
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 Table 12 reports the insulin, glucose, cholesterol, and triglyceride levels for the 
sample.  The right column of the table shows the desirable or healthy ranges for these risk 
factors.  As shown in this table, the means for this sample all fell within the desirable range, with 
the exception of HDL levels falling slightly below the healthy value.   
Clinic and Ambulatory Blood Pressure 
Clinic blood pressure was assessed at two different time points for the 6 year follow-up 
(visit 1 and visit 6).  We took the average of the final two readings (out of three) at both time 
points and then averaged the clinic BPs from these two timepoints.  Daytime ambulatory blood 
pressure was averaged over all available data across the three days of ambulatory monitoring, 
and nighttime ambulatory blood pressure was averaged over all available data across the two 
monitoring nights.  Tables 13 and 14 display the correlation matrices for the relationship among 
clinic, daytime, and nighttime BP for both systolic and diastolic BP.  Variables adjusted for in 
the regression analyses examining daytime and nighttime ABP are shown in tables 15 and 16. 
Table 17 displays the mean and standard deviations for CBP and ABP.  Tables 18 – 20 compare 
the blood pressure values by gender, race, and hypertensive status.  Males (n=101) had 
significantly higher nighttime DBP (64.37 vs 61.91 mmHg, p=.04) than females (n=100).  There 
were no significant differences in clinic or ambulatory BP by race or medication status.  
Carotid IMT 
Covariates adjusted for in the analyses are displayed in Table 21.  Table 22 displays the 
means and standard deviations for carotid IMT values for the entire sample, as well as the results 
from the t-tests comparing the means among gender, race, age, and hypertensive status.  One-
way ANOVA was used to examine carotid IMT values by education status. Males (n=101) had 
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significantly higher IMT values (0.94 mm vs. 0.82 mm, p=.0001) than females (n=100).  
Hypertensive participants (n=66) had significantly higher IMT levels (0.93 mm vs. 0.85 mm, 
p=.01) than normotensive participants (n=135).  Older participants had significantly higher IMT 
levels (0.94 mm vs. 0.82 mm, p<.001) than younger participants. There were no significant 
differences in carotid IMT values by race or education status.  
Physical Activity Variables 
For descriptive purposes, the Paffenbarger Physical Activity Questionnaire (61) was 
examined to determine if this particular sample could be classified as physically active or 
inactive. Table 23 shows the average minutes per week, MET values, and number of activities 
for this sample, as reported on the Paffenbarger.    Since the minutes per week data was skewed, 
the median value for minutes per week is also displayed in the table.  According to the Centers 
for Disease Control and Prevention (CDC) and the American College of Sports Medicine 
(ACSM), individuals should engage in 30 minutes or more of moderate-intensity physical 
activity on most (preferably all) days of the week (62).  Intensity can be defined as the rate of 
energy expenditure during exercise and is usually expressed in metabolic equivalents (METS).  
Moderate intensity activities are those performed at an intensity of about 4 to 6 METS.  
Therefore, the METS column in Table 23 refers to the mean intensity of the participants’ 
activity.  This sample is reaching the recommended activity intensity levels (around 5 METS), 
however, the amount of activity is insufficient to classify this sample as physically active (only 
about 75 minutes per week). 
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The purpose of the first specific aim was to examine the association of carotid 
IMT with daytime and nighttime ABP.  Standard covariates plus risk factors that significantly 
predicted IMT (waist circumference) were entered into the models.  First, partial correlations, 
controlling for gender, age, race, clinic BP, and waist circumference were used to examine the 
association of IMT with daytime and nighttime BP in separate models. Carotid IMT was 
significantly associated with both daytime SBP (r=.18, p=.01) and nighttime SBP (r=.18, p=.01).  
These two values were, obviously, not significantly different.  Carotid IMT was neither 
associated with daytime DBP (r=.11, p=.11) nor nighttime DBP (r=.09, p=.19).   
Regression analysis was used to examine the extent to which associations involving 
daytime and nighttime ABP were independent.  Daytime SBP, daytime DBP, nighttime SBP, and 
nighttime DBP were all entered separately into a regression model, controlling for gender, age, 
race, waist circumference, and clinic BP.  When entered separately into the model, both daytime 
SBP (F(1, 194)=6.33, p=.01) and nighttime SBP (F(1, 194)=6.46, p=.01) significantly predicted 
carotid IMT, as reported above.  However, when both daytime and nighttime SBP were entered 
simultaneously, both daytime SBP (F (1,193)=1.81, p=.18) and nighttime SBP (F(1, 193)=1.94, 
p=.17) lost their significance.  Neither daytime DBP (F(1,194)=2.53, p=.11) nor nighttime DBP 
(F (1, 194)=1.73, p=.19) significantly predicted carotid IMT. 
Exploratory analyses were examined differences in these associations as a function of 
hypertensive status.  Hypertensive status significantly moderated the effects of daytime SBP (F 
for interaction (1, 192)=4.57, p=.01) and nighttime SBP (F for interaction (1, 192)=4.81, p=.009) 
on carotid IMT. Neither daytime SBP (F (1, 128)=2.70, p=.1) nor nighttime SBP(F (1, 
128)=2.51, p=.12) were significantly associated with carotid IMT in normotensive participants.  
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For hypertensive participants, however, both daytime SBP (F (1, 59)=8.70, p=.006) and 
nighttime SBP (F(1, 59)=5.90, p=.02) were significantly associated with carotid IMT.  When 
both daytime SBP (F(1, 58)=3.22, p=.08) and nighttime SBP (F(1, 58)=1.08, p=.3) were entered 
simultaneously into a regression model, both lost their significance with carotid IMT.   
Neither daytime DBP (F(1, 128)=.30, p=.58 nor nighttime DBP (F(1, 128)=.53, p=.47) 
were significantly associated with carotid IMT in normotensive participants.  For DBP in the 
hypertensive group, daytime DBP (F(1, 59)=3.84, p=.06), but not nighttime DBP (F(1, 59)=.08, 
p=.78) was marginally associated with carotid IMT.   
SPECIFIC AIM 2 
Within-Person Analysis 
The purpose of this aim was to examine the within-person association of daytime 
physical activity with daytime ABP.  M ulti-level modeling (Proc-Mixed) was used.   T hree 
measures of physical activity were employed as predictors: wrist-based accelerometry, waist-
based accelerometry, and self-reported physical activity.  Activity counts for both accelerometers 
were averaged over 1, 5, 10, and 15 minutes prior to each BP reading.  Given the prevalence of 
low activity counts in conjunction with the positive skew of the data, quartiles were used for the 
accelerometry data except for the 1 minute intervals.  About 50% of the distribution of activity 
counts for the minute prior to ABP reading were at 0 counts for both PA devices.  Therefore, 1 
minute intervals were classified into binary categories (0 counts, >0 counts).  T ables 24 - 25 
show the results of the within-person analysis for the 1, 5, 10,  and 15 minute intervals.  All the 
time intervals prior to ABP reading for both the wrist and waist-based accelerometer were 
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significant independent predictors of both daytime SBP and DBP.  S elf-reported physical 
activity, which was based on the 10 minutes prior to ABP measurement, was also a significant 
predictor of both daytime SBP and DBP.  
Mean daytime ABP readings were regressed on wrist and waist-based accelerometry 
variables (separate models for SBP and DBP) (Tables 26 – 27). Wrist accelerometry for SBP 
(t=5.87, p<.001) and DBP (t=6.93, p<.0001) was an independent, significant predictor when 
taken 1 minute prior to ABP measurement, but waist accelerometry for SBP (t=.39, p=.69) and 
DBP (t=1.32, p=.19) lost its significance.  For all other time intervals, both wrist and waist 
accelerometry remained significant.  Tables 28 - 29 show the results for the 10 min physical 
activity measure prior to ABP measurement. All three (wrist, waist, self-report) were entered 
simultaneously into the model.  For daytime SBP, all three physical activity variables were 
associated with daytime SBP.  However, for daytime DBP, only wrist accelerometry 10 minutes 
prior to ABP measurement remained a significant predictor. 
Between-Person Analysis 
 Between-person analyses were conducted to determine the type of physical activity 
measure (wrist, waist, or self-report), and the time interval (1, 5, 10, 15 minutes) that has the 
greatest influence on daytime ABP.  Activity values, as well as ABP values, were averaged 
across readings and days for each person.  Due to its skewed distribution, mean waist 
accelerometry values were log transformed, while wrist accelerometry values had a normal 
distribution.  Regression analysis was used to examine the association of daytime ABP with 
physical activity.  Daytime SBP and DBP were examined separately.  Each activity measure was 
placed into a regression model predicting daytime SBP and DBP.  Table 30 displays the results 
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of the regression analysis for SBP.  For wrist accelerometry, only mean 1 minute interval values 
prior to ABP readings (F(1, 200)=14.17, p<0.001) were significantly associated with daytime 
SBP.  For waist accelerometry, mean values taken 5 minutes (F(1, 200)=4.50, p=.04), 10 minutes 
(F(1, 200)=5.00, p=.03), and 15 minute values (F(1,200)=3.90, p=.05) were significantly 
associated with daytime SBP.   Based on the relative effect sizes of these results (shown in Table 
30), it appears that average metabolic expenditure by waist accelerometry 10 minutes prior to 
ABP readings is more strongly associated with mean daytime SBP than either the 5 or 15 minute 
intervals.  To determine if multiple time intervals would more strongly account for physical 
activity effects, combinations of the significant time interval variables for waist accelerometry 
were placed into a regression model predicting daytime SBP (Table 31).  The results from this 
analysis indicated that combining these time intervals did not increase the variance accounted for 
in daytime SBP.  Therefore, we decided to place waist accelerometry 10 minutes (F(1, 
200)=4.50, p=.04) prior to ABP readings and mean activity counts via wrist accelerometry 1 
minute (F(1,200)=11.12, p=.001) prior to ABP readings simultaneously into a final regression 
model predicting daytime SBP (Table 32).  The final model suggests that when measured in this 
manner, between-person differences in physical activity just preceding ABP readings account for 
9% of the variance in daytime ambulatory systolic blood pressure. When mean posture was 
added to the model, it accounted for an additional 2% of the variance in daytime SBP.  For 
daytime DBP, it appears that only average wrist accelerometry one minute prior to ABP readings 
(F(1, 200)=4.47, p=.04) significantly predicts daytime DBP (Table 33).  No waist accelerometry 
measures significantly predicted average ambulatory DBP.  Time-averaged diary reports of 
physical activity prior to each ABP reading did not significantly predict either averaged daytime 
SBP (F(1, 200)=1.17, p=.28) or DBP (F(1, 200)=2.24, p=.19). 
28
SPECIFIC AIM 3 
The purpose of the third aim was to examine the association between daytime ABP and 
carotid IMT when controlling for mean daytime PA.  Mean daytime activity scores that were 
most strongly associated with daytime ABP were added to a regression model predicting carotid 
IMT.  When controlling for age, sex, race, waist circumference, clinic SBP, posture, one minute 
wrist accelerometry, and 10 minute waist accelerometry, daytime SBP was still significantly 
associated with carotid IMT (F(1,191)=6.18, p=.01).  The partial correlation between between 
activity-adjusted daytime SBP and IMT (r=.22, p=.0013) was marginally larger (p<.1) than the 
partial correlation between IMT and daytime SBP not adjusted for activity (r=.18, p=.01).  In a 
comparable model, daytime DBP was still not significantly associated with carotid IMT (F(1, 
191)= 2.12, p=.15.  Adjusting for mean posture did not significantly alter the relationship 
between daytime SBP and IMT, and therefore, was not adjusted for in the final model. 
SPECIFIC AIM 4 
The fourth specific aim was to compare nighttime ABP and daytime ABP with carotid 
IMT when controlling for concurrent daytime PA.  Activity-adjusted daytime ABP refers to the 
daytime ABP value that remains after partialling out the effects of daytime physical activity.  
There was no significant difference between the partial correlation between activit- adjusted 
daytime SBP and IMT, on the one hand (r=.22, p=.0013) and nighttime SBP and IMT on the 
other (r=.18, p=.01). 
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  When both daytime and nighttime SBP were entered simultaneously into a multiple 
regression model, nighttime SBP (F(1,193)=1.70, p=.19) lost its significance, but activity 
adjusted daytime SBP (F(1,193)=3.47, p=.06) was marginally associated with carotid IMT. 
When stratified by hypertensive status, neither activity-adjusted daytime SBP 
(F(1,128)=3.24, p=.07) nor activity adjusted daytime DBP (F(1,128)=.20, p=.66) were 
significantly associated with carotid IMT in normotensive participants though there was a trend 
towards significance with daytime SBP.  It appears that adjusting for PA may strengthen the 
association between daytime SBP (F=3.24 vs. F=2.70) and carotid IMT though it was not 
significant.  For hypertensive participants, activity-adjusted daytime SBP (F(1, 59)=9.24, 
p=.004) was significantly associated with carotid IMT, but activity-adjusted daytime DBP (F(1, 
59)=3.76, p=.06) was only marginally associated with carotid IMT.  When both activity-adjusted 
daytime SBP and nighttime SBP were entered simultaneously into a regression model, 
controlling for age, sex, race, BMI, and clinic SBP,  activity-adjusted daytime SBP remained a 
significant predictor (F(1,58)=3.89, p=.05) while nighttime SBP lost its association with carotid 
IMT (F(1,58)=.71, p=.4).   
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5.0  DISCUSSION  
 The purpose of this study was to examine the association of daytime and nighttime ABP 
with carotid IMT when controlling for daytime physical activity.  Based on the results of 
previous literature, we hypothesized that nighttime, when compared with daytime ABP, would 
be more strongly associated with carotid IMT, but we expected these effects to be accounted for, 
in part, by confounding influence of PA on the association between daytime ABP and carotid 
IMT.  Contrary to our expectation, however, we found that associations involving daytime and 
nighttime ABP with IMT were equivalent in magnitude.  There are several factors which may 
account for discrepant findings between our study and previous work, including sample 
characteristics and methodological differences (for example, we used wrist accelerometry to 
determine sleep and wake time whereas most of the previous literature used set intervals such as 
6am to 10pm for each person).  
While we showed that ABP was associated with increased risk, our data also suggested 
that these associations were stronger among some individuals than among others.  Similar to 
Boggia et al (27), we found that hypertensive status appeared to moderate the association 
between ABP and cardiovascular disease.  Namely, both daytime and nighttime SBP were more 
strongly associated with carotid IMT in participants currently on hypertensive medication or had 
clinical hypertension.   
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One of the unique features of this study involved its use of objective measures of physical 
activity as a means of reducing confounding influences on ABP.  In this respect, we found that 
both wrist and waist accelerometry, as well as self-report significantly predicted daytime ABP in 
within-person analyses.  For between-subject analyses, we found that 9% of variance in daytime 
SBP was explained by physical activity.  This finding was similar to Leary et al. who found that 
the percentage of variance in SBP explained by PA ranged from 7.1% to 10.7% between 
individuals though that particular sample was significantly younger and more active (46).  Our 
study also supports the use of the combination of both a wrist and waist accelerometer for 
estimating PA since both the wrist and waist accelerometer were independently predictive of 
ABP.  Interestingly, it appears that for wrist actigraphy, shorter intervals (1 minute) were more 
strongly associated with daytime ABP, while for waist actigraphy, 5 – 15 minute intervals had a 
greater influence on ABP fluctuations.  This finding is partially supported by previous studies.   
Costa et al found that lower energy expenditure during ABPM is partly the result of the 
requirement for immobility for the ABP device to take an accurate measurement (63).  
Therefore, any large movements immediately before ABP assessments, which would more likely 
be captured by the waist accelerometer, may be avoided.  However, smaller movements, which 
would more likely be captured by wrist accelerometry, would not be as likely to be avoided; 
there be more variability in these just prior to the ABP assessment, when compared to 
movements detected by the waist device, accounting for the greater predictive value of the wrist 
device at the 1 minute interval prior to ABP. 
We hypothesized that adjusting for daytime PA would strengthen the association between 
daytime SBP and carotid IMT.  Our hypothesis was partially supported.  Activity-adjusted 
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daytime SBP was more closely associated with IMT than daytime SBP that was not adjusted for 
activity, though these differences were not statistically significant.  In addition, activity-adjusted 
daytime SBP was a marginally significant independent predictor of IMT even after nighttime 
SBP was added to the model in a manner that was not the case when non-activity adjusted 
measures were used.  When we stratified the sample by hypertensive status, activity-adjusted 
daytime SBP was only marginally associated with carotid IMT in the untreated group. 
Interestingly, activity-adjusted daytime SBP was more closely associated with IMT than 
nighttime SBP in the hypertensive group.  Though we didn’t find significant associations 
between ABP and carotid IMT in the normotensive group, this sample of people had reduced 
variance in IMT and ABP which may account for this difference between the groups. 
 Several limitations of this study should be noted.  First, there were a significantly higher 
number of daytime ABP assessments over nighttime assessments.  However, according to Llabre 
et al., who examined the number of ABP readings necessary to estimate BP with acceptable 
reliability, a total of 6 SBP measurements were needed to ensure adequate levels of 
generalizability (66). The mean number of nighttime ABP measurements for our study was 11, 
with the majority of participants having at least 6 nighttime measurements.   Therefore, it is 
likely that there were a sufficient number of ABP readings for both nighttime as well as daytime 
ABP in his sample.  Another potential limitation: the majority of the sample, even though it was 
representative of the Pittsburgh area, was mainly Caucasion, and therefore, these results may not 
be representative of other populations.  In addition, a significant number of participants were 
excluded from this study due to missing data.     
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 In addition to its limitations, this study also has considerable strengths. This is the first 
study, to our knowledge, that has examined the influence of daytime PA in altering the 
association between ABP and cardiovascular risk. Previous ABP literature has only examined 
daytime and nighttime ABP in a single 24 hour period.  This study examined daytime ABP over 
a 3 day period and nighttime ABP over a 2 night period which increases the reliability of these 
results.  Also, this study was one of the first to utilize both a wrist and waist accelerometer, along 
with self-report, to estimate daytime PA and its effect on daytime ABP.  We were able to 
determine that the optimal time intervals for assessing the relationship between daytime PA and 
ABP may differ between PA devices, and that the combination of these devices are more likely 
to capture the effect of PA on daytime ABP.  Both the wrist and waist accelerometer explained a 
significant amount of the variance in daytime ABP (6% for 1 minute wrist, 3% for 10 minute 
waist) that wouldn’t be captured by the use of a single activity device. Finally, this was one of 
the first studies of this kind to use wrist accelerometry, an objective measure, rather than set 
daytime and nighttime intervals or self-report to determine sleep and wake times. 
 The results from this study tell us that acute physical activity suppresses the relationship 
between daytime SBP and carotid IMT, although the magnitude of this effect appears to depend 
on the population examined.  Adjusting for physical activity may be more important for 
hypertensive populations or those that are physically active.   For these populations, adjusting for 
physical activity may significantly alter the relationship between daytime ABP and carotid IMT, 
and therefore, it may be necessary for future studies to control for in order to better understand 
the relationship between daytime ABP and IMT. There are several areas that warrant further 
research.  It would be of interest to examine the effect of nighttime PA on nighttime ABP and 
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carotid IMT.  Unlike daytime PA, the effects of nighttime PA on nighttime ABP may add to the 
association of nighttime ABP and carotid IMT rather than suppress it.  Finally, future studies 
should examine the differences among normotensives, hypertensives, and participants on 
hypertensive medication in the association of ABP and carotid IMT, as well as their response to 
exercise.  Unfortunately, this study did not have enough subjects in order to examine each of 
these groups individually with a sufficient sample size in each.  By examining these populations 
separately, we may better understand the underlying mechanisms for that may influence the 
association of both daytime and nighttime ABP with cardiovascular risk. 
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6.0  CONCLUSIONS 
This was the first study, to our knowledge, to examine the relationship between daytime 
and nighttime ABP with carotid IMT when controlling for daytime PA.   The utility of using 
both a wrist and waist accelerometer in examining PA was supported in this study.  We did not 
confirm the superiority of nighttime ABP over daytime ABP in a general population.  We did 
find partial support for the prognostic significance of daytime SBP when controlling for PA, 
which was found to be a suppressor variable, especially among hypertensive individuals.  This 
finding supports the specific prognostic importance of daytime ABP and, to that extent, may 
support work on a  greater understanding of the daytime variables that uniquely influence 
daytime ABP such as daily psychosocial stress, as potential correlates of cardiovascular risk. 
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APPENDIX A 
CHARTS AND TABLES 
 
A.1 APPENDIX SECTION 
 Table 1: ABP vs CBP in a general population 
Reference Study Population Study Design Measures Results 
*Hansen et al 
2006 
 
(8) 
N=1700 Danish general 
population, 47% 
female, aged 41 to 72 
yrs,  9% taking 
antihypertensive 
medication 
Prospective, mean 
follow-up of 9.5 yrs, 
ABPM was done every 
15 min between 7am 
and 11pm and every 30 
min between 11pm and 
7 am. 
CBP, 24 hr ABP, 
cardiovascular 
mortality, ischemic 
heart disease, stroke 
In a multivariate Cox 
proportional hazard 
models that adjusted 
for CBP, ABP 
significantly predicted 
all endpoints (p<.001), 
while CBP lost its 
significance when ABP 
was adjusted for in the 
model (p>.17). 
Hansen et al. 
2007 
 
(10) 
N=7030 general 
population from IDACO, 
44.8% women, mean 
age 56.2 yrs, 21.8% on 
antihypertensive 
medication 
Prospective, median 
follow –up 9.5 yrs, 
ABPM was done every 
15 to 30 min during the 
daytime. There was no 
ABPM during nighttime 
hours. 
CBP, 24 hr ABP, fatal 
and nonfatal stroke, 
coronary events, 
cardiac events, 
composite 
cardiovascular 
endpoint: included all 
aforementioned 
endpoints plus 
cardiovascular mortality 
In a multivariate Cox 
regression model that 
adjusted for CBP, 
daytime ABP was a 
significant predictor of 
cardiovascular mortality 
(p<.01) whereas CBP 
was not significant 
(p>.05). 
Kikuya et al. 
2005 
 
(11) 
N=1332 general 
population from 
Ohasama Study, 65% 
female, mean age 61.8 
yrs 
Prospective, mean 
follow-up 10.8 yrs 
CBP, 24 hr ABP, 
mortality from 
cardiovascular disease 
and noncardiovascular 
disease 
When CBP and ABP 
were simultaneously 
entered into a 
multivariate Cox 
regression model, only 
ABP was significantly 
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related to 
cardiovascular mortality 
risk (p<.05). 
Sega et al. 
2005 
 
(12) 
N=2051 general 
population, 50% 
female, 25 to 74 yrs 
Prospective, mean 
follow-up 10.92 yrs, 
ABPM was done every 
20 min during the 24 hr 
period. HBPM was 
done at 7am and 7pm 
in the subject’s home 
with a semiautomatic 
device. 
CBP, 24 hr ABP, HBP, 
Cardiovascular 
mortality 
Using Cox proportional 
hazards model, the risk 
of death increased 
more with a given 
increase in  ABP than 
in CBP, but the overall 
ability to predict death 
was not  significantly 
greater in ABP over 
CBP (p<.05). 
*Other studies using the same population have found similar results using different 
cardiovascular endpoint. 
Table 2: ABP vs CBP in a Hypertensive Population 
Reference Study Population Study Design Measures Results 
Dolan et al.  2005 
(13) 
N=5932 untreated 
hypertensives, 49% 
female, mean age 
61.13 yrs 
Prospective, mean  
follow-up of 7.9 yrs, 
ABPM done every 30 
min over 24 hrs 
 CBP, 24 hr ABP,  
cardiac mortality, 
cardiovascular mortality 
When entered into the 
same multivariate Cox 
proportional hazards 
regression model, ABP 
had significantly higher 
hazard ratios than CBP 
(p<.001) 
Dolan et al. 2009 
(14) 
N=1905 treated 
hypertensives, 33% 
female, mean age 
40.79 yrs 
Prospective, median 
follow-up of 5.5 yrs, 
ABPM was done 
every30 min throughout 
a 24 hr period 
CBP, 24 hr ABP, total 
cardiovascular events, 
total coronary events, 
fatal and nonfatal 
stroke 
A multivariate Cox 
proportional hazards 
regression model found 
that systolic ABP was 
an independent 
predictor of stroke 
(p<.002) and both ABP 
and CBP were 
independent predictors 
of cardiovascular 
events (p<.002). 
Staessan et al. 1999 
(15) 
N=808 untreated 
systolic hypertensives, 
62% female, mean age 
69.6 yrs, 42.6% treated 
with anti-hypertensive 
drugs  
Prospective, mean  
follow-up 4.4 yrs, 
ABPM done every 30 
min over 24 hrs. 
CBP, 24 hr ABP, total 
and cardiovascular 
mortality, all 
cardiovascular 
endpoints, fatal and 
nonfatal cardiac 
endpoints 
Using a multivariate 
Cox regression 
analysis, ABP 
significantly predicted  
cardiovascular 
mortality, all 
cardiovascular end 
points, and fatal and 
nonfatal stoke (p<.05), 
while CBP was not a 
significant predictor in 
untreated 
hypertensives. 
Eguchi et al. 2008 
(16) 
N=1268 untreated 
hypertensives, 301 had 
type 2 diabetes, 62% 
female, mean age 70.4 
yrs 
Prospective, mean  
follow-up 4.17 yrs, 
ABPM was done every 
30 min over a 24 hr 
period. 
CBP, 24 hr ABP, 
stroke, fatal or nonfatal 
myocardial infarction, 
sudden cardiac death 
When CBP and ABP 
were simultaneously 
entered into a 
multivariate Cox 
regression model, ABP 
was a significant 
predictor of CVD in 
both the diabetes and 
nondiabetes group 
(p<.001) while CBP lost 
its significance (p>.05).  
Clement et al. 2003 N=1963 treated 
hypertensives, 48% 
female, mean age 56.5 
Prospective, mean 
follow-up 5 yrs, ABPM 
was done at intervals of 
CBP, 24 hr ABP, fatal 
and nonfatal 
cardiovascular events, 
Using a multivariate 
Cox regression 
analysis, ABP was a 
38
(17) yrs not more than 30 min 
between 8am and 8pm 
and at intervals of not 
more than 60 min 
between 8pm and 8am 
fatal or nonfatal 
myocardial infarction or 
stroke, death from any 
cause 
significant independent 
predictor of fatal and 
nonfatal cardiovascular 
events and fatal and 
nonfatal myocardial 
infarction or stroke 
(p<.05) after 
adjustment for CBP. 
 
Table 3: ABP and IMT in a General Population 
Reference Study Population Study Design Measures Results 
Kamarck et al. 
2002 
 
(18) 
N=216 general 
population, 48% 
female, 50-70 yrs old 
Cross-sectional, ABPM 
and ACBPM was done 
every 45 min over a 2.5 
hr period (4 readings 
total)  
Manual CBP, 
automated CBP, ABP, 
carotid IMT (CCA, 
carotid bulb, internal 
carotid, mean) 
Using regression 
models that adjusted 
for demographic 
covariates and 
measures of manual 
and automated CBP, 
ABP was significantly 
associated with IMT 
(p<.01). 
Su et al. 
2006 
 
(19) 
N=186 general 
population, 13% 
female, mean age 55.7 
yrs 
Cross-sectional, ABPM 
was done every 15 min 
from 7am to 10pm and 
every 30 min from 
10pm to 7am. 
CBP, 24 hr ABP, 
carotid IMT (CCA, 
carotid bulb, internal 
carotid artery, 
maximum) 
A multivariate 
regression model that 
examined ABP and 
CBP separately found 
that ABP was a 
significant risk factor of 
carotid IMT at the CCA 
and carotid bulb (p<.05) 
while CBP was not 
significantly associated 
with any of the IMT 
measures (p>.05). 
Nystrom et al. 
2005 
 
(20) 
N=170 hypertensives 
and 23 normotensives, 
31% female, mean age 
54 yrs 
Cross-sectional, ABPM 
was done at 20 min 
intervals throughout the 
24 hr period. 
CBP, 24 hr ABP, 
carotid IMT (CCA, 
mean) 
Using Pearson 
correlations, this study 
found that carotid IMT 
significantly correlated 
with both ABP (p<.001) 
and CBP (p<.001) 
equally well. 
 
Dechering et al. 
2009 
 
(21) 
N=532 general 
population, 48.3% 
female, mean age 38.9 
yrs 
Cross-sectional, ABPM 
done every 20 min from 
8am to 10pm and every 
45 min from 10pm to 
8am 
CBP, 24 hr ABP, 
carotid IMT (CCA , 
mean) 
In regression models 
that adjusted for CBP, 
systolic ABP was 
significantly associated 
with carotid IMT 
(p=.002), while CBP 
was not (p=.66) 
 
Table 4: ABP and IMT in a Hypertensive Population 
Reference Study Population Study Design Measures Results 
Gaborieau et al. 2008 
 
(22) 
N=325 treated (70%) 
and untreated 
hypertensives, 41% 
female, mean age 64.5 
yrs 
Cross-sectional, HBPM 
was done over 4 days 
with 3 measures done 
in the morning and 3 
measures in the 
evening.  ABPM was 
done every 20 min by 
day and every 60 min 
at night over a 24 hr 
period. 
CBP, HBP, 24 hr ABP, 
carotid IMT (CCA, 
mean) 
Using linear regression,  
ABP (p<.0001) was 
more significantly 
associated with IMT 
than CBP(p<.01), 
though the difference 
was not significant. 
Zanchetti et al. 2001 
 
N=508 hypertensives 
with moderate 
Cross-sectional, ABPM 
was done every 15 min 
CBP, 24 hr ABP, 
carotid IMT (eight near 
In a multiple regression 
analysis, systolic ABP 
39
(23) hypercholestrolaemia, 
59.8% female, mean 
age 58.4 yrs 
during the 24 hr period. and far walls of the 
carotid bifurcations and 
CCA, mean and 
maximum) 
was significantly 
associated with all 
carotid IMT measures 
(p<.05), while CBP was 
not significantly 
associated with IMT. 
Mancia et al. 2001 
 
(24) 
N=1663 hypertensives, 
45.6% female, 56.2 yrs, 
off of antihypertensive 
medication prior to 
study 
Cross-sectional, ABPM 
was done every 15 min 
during the day and 
every 20 min during the 
night over a 24 hr 
period. 
CBP, 24 hr ABP, 
carotid IMT (12 different 
carotid sites, mean and 
max) 
Multiple regression 
analysis showed that 
systolic ABP was 
significantly associated 
with maximum and 
mean IMT (p<.0001) 
while CBP was not 
(p>.05). 
 
Table 5: Daytime vs Nighttime ABP in a General Population 
Reference Study Population Study Design Measures Results 
 
Ben-Dov et al. 
2007 
 
(25) 
N=3957 general 
population, aged 16 to 
93 yrs, 58% on 
antihypertensive 
medications 
Prospective, mean 
follow-up 6.5 yrs, 
ABPM done every 20 
min between 6am and 
midnight and every 30 
min between midnight 
and 6am for a 24 hr 
period 
Daytime ABP, nighttime 
ABP, all-cause mortality 
When entered into the 
same multivariate 
model, nighttime BP 
(p<.001)had a 
significantly higher 
hazard ratio then 
daytime BP, which 
suggests that  it is a 
greater independent 
predictor of 
cardiovascular disease. 
Pickering et al. 
2007 
 
(26) 
N= 8945 general 
population, 47% 
female, mean age 
60.29 yrs, participants 
using antihypertensive 
medication had them 
withdrawn at least 2 
weeks before 
monitoring 
Database from 7 
prospective studies, 
mean follow-up 5.8 yrs, 
ABPM done every 15 to 
30 min over 24 hour 
period 
Daytime ABP, nighttime 
ABP, fatal and nonfatal 
stroke, cardiac events  
When both daytime and 
nighttime SBP were 
included as predictors 
for cardiac events, only 
daytime SBP was 
statistically significant 
(p=0.0004), suggesting 
that daytime ABP may 
be a better predictor 
than nighttime ABP for 
cardiac events.  When 
both daytime and 
nighttime ABP were 
included as predictors 
for stroke, nighttime 
ABP was a statistically 
stronger predictor 
(p=0.002) though 
daytime ABP was still a 
significant predictor 
(p=0.008) as well. 
Boggia et al. 
2007 
 
(27) 
N=7458 general 
population from IDACO, 
46% female, mean age 
56.8 yrs, 46% 
hypertensives with 48% 
on antihypertensive 
drugs 
Prospective, median 
follow -up 9.6 yrs, ABP 
at intervals from 15 to 
30 min during daytime 
and from 30 to 60 min 
at nighttime 
Daytime ABP, nighttime 
ABP, fatal and nonfatal 
stroke, coronary 
events, cardiac events 
In a multivariate 
regression model that 
adjusted for daytime 
BP, nighttime BP was a 
significant predictor of 
total, cardiovascular, 
and noncardiovascular 
mortality (p<.0001)  
while daytime BP lost 
its significance. 
Hansen et al. 
2006 
 
(8) 
N=1700 Danish general 
population, 47% 
female, aged 41 to 72 
yrs , 9% were taking 
Prospective, mean 
follow-up of 9.5 yrs, BP 
recordings made every 
15 min between 7am to 
Daytime ABP, nighttime 
ABP, cardiovascular 
mortality, ischemic 
heart disease, stroke 
When systolic daytime 
and nighttime ABP 
were entered into the 
same multivariate 
40
antihypertensive 
medication 
11pm and every 30 min 
between 11pm and 
7am 
model, only daytime 
ABP was a significant 
predictor (p=.02), 
whereas nighttime ABP 
lost its significance 
(p=.24).  When diastolic 
daytime and nighttime 
ABP were entered, both 
daytime (p=.05) and 
nighttime BP (p=.02) 
were significant 
predictors of 
cardiovascular disease. 
Kikuya et al. 
2005 
 
 
(11) 
N=1332 general 
population from 
Ohasama Study, 65% 
female, mean age 61.8 
yrs, 30.4% were taking 
antihypertensive 
medications 
Prospective, mean 
follow-up 10.8 yrs, 
ABPM was done every 
30 min over a 24 hr 
period. 
Daytime ABP, nighttime 
ABP, mortality from 
cardiovascular and 
noncardiovascular 
disease 
A multivariate Cox 
proportional hazards 
regression model found 
that, when both daytime 
and nighttime ABP 
were entered 
simultaneously, only 
nighttime systolic ABP 
was significantly related 
to cardiovascular 
mortality risk (p<.05). 
Sega et al 
2005 
 
(12) 
N=2051 general 
population, 50% 
female, 25 to 74 yrs 
Prospective, mean 
follow-up 10.91 yrs, 
ABPM was done every 
20 min during the 24 hr 
period. HBPM was 
done at 7am and 7pm 
with a semiautomatic 
device. 
Daytime ABP, nighttime 
ABP, cardiovascular 
mortality 
In a multivariate 
analysis, goodness of 
fit was improved by 
adding nighttime ABP 
to CBP (p=.003), but it 
was not improved when 
daytime ABP was 
added to CBP (p=.428) 
Metoki et al. 
2006 
 
(28) 
N=1360 general 
population from 
Ohasama Study, 64% 
female, mean age 61.3 
yrs, 30% receiving 
antihypertensive 
medication 
Prospective, mean 
follow-up 10.6 yrs, 
ABPM measured every 
30 min for 24 hours, 
day broken into 2 hour 
segments with 4 ABP 
readings per segment 
Daytime ABP, nighttime 
ABP, cerebro and 
cardiovascular disease, 
haemorrhagic stroke, 
cerebral infarction, 
heart disease 
An elevated nighttime 
ABP was associated 
with increased cerebral 
infarction mortality and 
heart disease mortality 
(p<.002)whereas 
elevated daytime ABP 
was associated with 
increased intracerebral 
haemorrhage mortality 
(p<.002). 
 
 
Table 6: Daytime vs Nighttime ABP in Hypertensives 
Reference Study Population Study Design Measures Results 
Fagard et al. 2008 
 
(29) 
N=3468 hypertensives, 
55% female, mean age 
61 yrs, 61.4% on 
antihypertensive 
medication 
Meta-analysis from 4 
prospective studies in 
Europe, median follow-
up 6.57 yrs, ABPM was 
done every 15 min or at 
intervals of not more 
than 30 min during the 
daytime and every 30 
min or not more than 60 
min during the 
nighttime over 24 
hours. 
Daytime ABP, nighttime 
ABP, all-cause 
mortality, CV mortality, 
NCV mortality, coronary 
heart disease, fatal and 
nonfatal stroke, major 
CV events 
In a multivariate Cox 
proportional hazards 
regression model, when 
adjusting for daytime 
ABP, nighttime ABP 
significantly predicted 
all-cause mortality CV 
mortality, CVD, CHD, 
and stroke (p<.05). 
When adjusting for 
nighttime ABP, daytime 
ABP did not 
significantly predict any 
of the endpoints(p>.05). 
Dolan et al. 2005 
 
N=5932 untreated 
hypertensives, 49% 
Prospective, mean 
follow-up of 7.9 yrs 
Daytime ABP, nighttime 
ABP,  all-cause 
In a multivariate Cox 
proportional hazards 
41
(13) female, mean age 
61.13 yrs 
mortality, 
cardiovascular, 
mortality , stroke, 
cardiac mortality 
model that adjusted for 
daytime ABP, nighttime 
ABP significantly 
predicted total, 
cardiovascular, stroke, 
and cardiac mortality 
(p<.05), whereas 
daytime ABP was only 
a significant predictor of 
all-cause mortality 
(p<.05). 
Dolan et al. 2009 
 
(14) 
N=1905 treated 
hypertensives, 33% 
female, ages 40-79 yrs 
Prospective, median 
follow-up of 5.5 yrs, 
ABPM was done every 
30 min throughout a 24 
hr period 
Daytime ABP, nighttime 
ABP, total 
cardiovascular events, 
total coronary events, 
fatal and nonfatal 
stroke 
A multivariate Cox 
proportional hazards 
regression model found 
that nighttime systolic 
ABP was a more 
significant predictor of 
stroke (p<.007)and 
cardiovascular events 
(p=.004)than daytime 
ABP. 
Staessan et al. 1999 
 
(15) 
N=808 untreated 
systolic hypertensives, 
62% women, ≥ 60 yrs 
Prospective, mean 
follow-up of 4.4 yrs, 
ABPM done every 30 
min over a 24 hr period. 
Daytime ABP, nighttime 
ABP, total and 
cardiovascular 
mortality, all 
cardiovascular 
endpoints, fatal and 
nonfatal cardiac 
endpoints 
In a multivariate Cox 
regression model, 
nighttime ABP was a 
significant predictor of 
cardiovascular 
mortality, all 
cardiovascular, stroke, 
and cardiac endpoints 
(p<.05) while daytime 
ABP was not (p>.05). 
Eguchi et al. 2008 
 
(29) 
N=1268 untreated 
systolic hypertensives, 
301 had type 2 
diabetes, 62% female, 
mean age 70.4 yrs,  
Prospective, mean 
follow-up 4.17 yrs, 
ABPM was done every 
30 min over a 24 hr 
period. 
Daytime ABP, nighttime 
ABP, stroke, fatal or 
nonfatal myocardial 
infarction, sudden 
cardiac death 
In a multivariate Cox 
regression model, the 
standard deviations of 
nighttime ABP was 
significantly associated 
with CVD (p<.05), 
independent of other 
covariates. 
Fagard et al. 2008 
 
(31) 
N=302 hypertensives 
with CV disease out of 
a total population of 
3295 hypertensives, 50 
% female, mean age 69 
yrs, 61.9% were taking 
antihypertensive 
medication 
Meta-analysis from 3 
prospective studies in 
Europe, median follow-
up 6.7 yrs, ABPM was 
done every 15 min or at 
intervals of not more 
than 30 min during the 
daytime and every 30 
min or at intervals of 
not more than 60 min 
during the nighttime 
during the 24 hr period. 
Daytime ABP, nighttime 
ABP, all-cause 
mortality, 
cardiovascular 
mortality, major 
cardiovascular events 
In a multivariate Cox 
regression analysis, 
when daytime and 
nighttime ABP were 
both included in the 
model, nighttime ABP 
significantly predicted 
all-cause mortality, CV 
mortality, and CV 
deaths (p<.05), while 
daytime ABP did not 
(p>.05). 
Burr et al. 2008 
 
(32) 
N=1144 untreated 
hypertensives, 49% 
female, mean age 75.1 
yrs 
Prospective, mean 
follow-up 6.7 yrs, 
ABPM was done every 
30 min over the 24 hr 
period. 
Daytime ABP, nighttime 
ABP, cardiovascular 
mortality, cardiac 
mortality, stroke 
In a multivariate Cox 
proportional hazards 
model, nighttime ABP 
was the highest 
independent predictor 
of  cardiovascular 
events and mortality 
(p<..001). 
 
Table 7: Nighttime ABP and Carotid IMT in a general population 
 
Reference Study Population Study Design Measures Results 
Shintani et al. 
2007 
N=775 general 
population, mean age 
Cross-sectional, ABPM 
was done every 30 min 
Daytime ABP, nighttime 
ABP, carotid IMT 
When both daytime and 
nighttime systolic ABP 
42
 
(33) 
66.2 ± 6.2 yrs, 68.8% 
women, 39% taking 
antihypertensive 
medication. 
during a 24 hr period (mean, CCA) were entered into the 
same multivariate 
regression analysis, 
only nighttime ABP was 
significantly associated 
with carotid IMT 
(p<.0001). 
Sander et al. 
1996 
 
(34) 
N= 208 hypertensive, 
216 normotensive, > 55 
yrs, 47% women 
Cross-sectional, 
normotensives and 
hypertensives 
24 hour ABP, BP 
variability, daytime 
ABP, nighttime ABP, 
carotid IMT (mean, 
CCA) 
Using ANCOVA to 
examine the differences 
between hypertensives 
and norrmotensives, it 
was found that 
increased diurnal 
systolic BP and 
increased nocturnal BP 
were associated with 
sig larger IMT values in 
the hypertensive group 
(p<0.0001) 
Cuspidi et al. 
2001 
 
(35) 
N=118 untreated 
hypertensives, mean 
age 46 yrs, 38% female 
Observational cross-
sectional study, 2 
groups: dippers, 
nondippers, ABPM was 
done at 15 min intervals 
during the daytime and 
20 min intervals during 
the nighttime for two 24 
hr periods within a 3 
week period. 
nocturnal BP dipping, 
carotid IMT (CCA, 
mean) 
An independent 
samples t-test found 
mean IMT was 
significantly greater in 
non-dippers than in 
dippers (p=.04). 
Muiesan et al. 
1996 
 
(36) 
N=225 general 
population, 48-64 yrs, 
48% women, 59 
subjects were excluded 
for taking 
antihypertensive 
medication 
Cross-sectional, ABPM 
was done every 20 min 
between 7am to 11pm 
and every 30 min 
between 11pm to 7am. 
24 hour ABP, daytime 
ABP, nighttime ABP, 
carotid IMT(mean, 
CCA, carotid 
bifurcation, extracranial 
portions of the internal 
and external carotid 
arteries) 
 In a multiple regression 
analysis, mean 
nighttime systolic ABP 
was independently 
related to mean carotid 
IMT (p<.05). 
 
Table 8:  Nighttime ABP and Carotid IMT in Hypertensives 
Reference Study Population Study Design Measures Results 
Salvetti et al. 2001 
 
(37) 
N=284 hypertensive 
subjects (59 treated), 
mean age 58 yrs, 50% 
women 
Cross-sectional, 
subjects divided into 
dippers, non-dippers, 
ABPM was done every 
20 min from 7am to 
11pm and 30 min from 
11pm to 7am. 
Nocturnal dip, carotid 
IMT (CCA, carotid 
bifurcation, extra cranial 
portions of internal and 
external carotid 
arteries, mean) 
Using ANCOVA to 
analyze the difference 
between dippers and 
non-dippers, mean IMT 
of all three carotid 
measurements was 
significantly greater in  
non-dippers than in 
dippers (p<.05). 
 
Pierdomenico et al. 
1997 
 
(38) 
N=90 untreated 
hypertensives, 49 yrs, 
44% female 
Cross-sectional, 25 
dippers, 25 non-
dippers, ABPM was 
done every 15 min from 
6am to midnight and at 
30 min from midnight to 
6am. 
BP dipping, carotid IMT 
(CCA, mean) 
The results from 
ANCOVA that 
compared dippers and 
non-dippers found that 
mean IMT was 
significantly higher in 
non-dippers than 
dippers (p<.02). 
Desideri et al. 2007 
 
(39) 
N=50 untreated male 
hypertensives, mean 
age 53.8 yrs, 25 
normotensive males, 
mean age 51.7 yrs 
Cross-sectional, 25 
hypertensive dippers, 
25 hypertensive non-
dippers, 25 controls, 
ABPM was done every 
15 min from 7am to 
24 hr ABP, nighttime 
ABP, nocturnal dip, 
carotid IMT (CCA, 
mean) 
The results from 
ANOVA found 
comparing dippers, 
non-dippers, and 
controls found that 
mean carotid IMT was 
43
11pm and every 30 min 
from 11pm to 7am 
significantly higher in 
non-dippers (.80 mm) 
and dippers (.73mm) 
than in controls 
(.48mm) (p<.05).  
Spearman correlations 
found a significant 
association between 
IMT and nighttime ABP 
(p=.04). 
 
CBP = clinic blood pressure 
ABP = ambulatory blood pressure 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
CCA = common carotid artery 
 
 
 
Table 9. Sample Characteristics (n=201) 
Variable   n (%)    M (SD)   Range 
Women   100 (49.75) 
Race 
 White   176 (87.13) 
 Black                                  19 (9.45) 
 Asian                                  3 (1.57) 
 Other                 3 (1.57) 
Education Status 
 High School or Less 46 (22.89) 
 Some College  39 (19.40) 
 Bachelor’s Degree 58 (28.86) 
 Graduate Degree 58 (28.86) 
Hypertensive Medication 57 (28.36) 
44
Age        66.86 (4.52)  56.1 – 76.7 
BMI        27.62 (4.77)  16.12 – 47.78 
*For gender, race, and education, the numbers in the tables represent the number of participants in that particular category, 
while the number in parenthesis indicates the % that number represents in the sample. 
**For age and BMI, the numbers represent the mean value, while the numbers in parenthesis indicates the standard deviation. 
 
 
Table 10: Demographic Characteristics by Hypertensive  Status (n=201) 
Variable  Hypertensive (n=57)  Normotensive (n=144)  p-value 
Women   31 (46.97)                                        69 (51.11)                              .58 
Race                                                                                                                                                            .37 
 White   57 (87.72)                                        119 (88.15)                                     
 Non White                          9 (13.64)                                         16 (11.85) 
  
Education Status                                                                                                                                       .64 
 High School or Less 18 (27.27)                                       28 (20.74) 
 Some College  12 (18.18)                                       27 (20) 
 Bachelor’s Degree 16 (24.20)                                        42 (31.11) 
 Graduate Degree 20 (30.30)                                        38 (28.15) 
Age    67.8 (4.54)   66.4 (4.45)       .04 
BMI    28.09 (4.76)   27.43 (4.79)       .38 
*For gender, race, and education, the numbers in the tables represent the number of participants in that particular category, 
while the number in parenthesis indicates the % that number represents in the sample. 
**For age and BMI, the numbers represent the mean value, while the numbers in parenthesis indicates the standard deviation 
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Table 11: Excluded and Included participants demographics 
Variable                           Excluded (n=95)                     Included (n=201)                     p-value 
N                                         98                                             191 
Women                             56 (58.95)                                100 (49.75)                               .14 
Age                                     67.32 (4.64)                             66.95 (4.35)                              .4 
Race 
White                               79 (83.16)                                 176 (87.56)                               .11 
Non White                       16 (16.84)                                 25 (12.44) 
Education                                                                                                                                .005 
     High School or Less 22 (23.16)                                 46 (22.89) 
     Some College 35 (36.84)                                 39 (19.40)                                                                  
     Bachelor’s Degree 14 (14.74)                                 58 (28.86) 
     Graduate Degree 24 (25.26)                                 58 (28.86) 
 
BMI                                  28.66 (4.72)                                 27.62 (4.77)                              .09 
Clinic SBP                        119.2 (12.39)                               118.8 (12.14)                           .19 
Clinic DBP                        75.64 (7.86)                                75.9 (7.58)                                .87 
IMT                                  .92 (.25)                                        .88 (.21)                                    .19 
 
 
Table 12: Risk Factor Values for Entire Sample (n=201) 
Variable    Total Sample (M, SD)   Desirable Range 
Insulin (mLU/mL)    13.14 (6.1)   5 – 20 mLU/mL 
Glucose (mg/dL)                 100.8 (18)                                        70 – 110 mg/dL 
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Total Cholesterol (mg/dL)                205.71 (37.6)                                   < 225 mg/dL 
HDL (mg/dL)     55.67 (16.1)                                     > 60 mg/dL 
LDL (mg/dL)     124 (36)                                            < 130 mg/dL 
Triglycerides (mg/dL)    127.3 (60.2)                                      78 – 158 mg/dL 
 
Table 13:  Correlation matrix for clinic and ambulatory SBP (n=201) 
 Clinic SBP Daytime SBP Nighttime SBP 
Clinic SBP 1.00 .45* .36* 
Daytime SBP .45* 1.00 .63* 
Nighttime SBP .36* .63* 1.00 
 
Table 14: Correlation matrix for clinic and ambulatory DBP (n=201) 
 Clinic DBP Daytime DBP Nighttime DBP 
Clinic DBP 1.00 .60* .47* 
Daytime DBP .60* 1.00 .62* 
Nighttime DBP .47* .62* 1.00 
 *p<.0001 
 
Table 15: Covariates Predicting Daytime Systolic Blood Pressure 
Covariates F-value P-value 
Age .24 .81 
Sex* 3.14 .08 
Race** 1.45 .23 
Education*** .46 .5 
*controlling for age 
**controlling for age, sex,  
***controlling for age, sex, race 
 
 
Table 16: Covariates Predicting Nighttime Systolic Blood Pressure 
Covariates F-value P-value 
Age .08 .78 
Sex* 1.33 .25 
Race** .80 .37 
Education*** .71 .4 
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*controlling for age 
**controlling for age, sex,  
***controlling for age, sex, race 
 
Table 17: Clinic BP and ABP for the Total Sample (n=201) 
Variable                                  Avg #                           Mean (SD)                                       Range 
Clinic SBP                                                                      118.8 (12.14)                               88 -  169 
Clinic DBP                                                                      75.9 (7.58)                                   56 - 97 
Daytime SBP                          48. 42                            136.08 (15.03)                            104.77 – 175.81 
Daytime DBP                         48.42                              76.58 (7.38)                                59.24 – 98.78 
Nighttime SBP                       11.03                              118.93 (17.06)                           76 – 178.20 
Nighttime DBP                      11.03                               63.04 (8.52)                               42.90 – 89.11 
*Avg # refers to the mean number of BP readings collected over the 3 days and 2 nights. 
 
 Table 18:  Clinic BP and ABP by Gender 
Variable                                         Males (n=101)           Females (n=100)                      P-value 
Clinic SBP                                       117.9 (11.55)             119.5 (12.70)                              .27 
Clinic DBP                                      76.64 (7.16)                75.19 (7.86)                                .17 
Daytime SBP                                137.8 (15.33)                134 (14.8)                                  .05 
Daytime DBP                               77.35 (7.33)                 75.79 (7.37)                                 .16 
Nighttime SBP                             120.2 (16.41)               117.5 (17.68)                              .29 
Nighttime DBP                            64.36 (7.87)                  61.91 (8.96)                                .04 
 
Table 19: Clinic BP and ABP by Race 
Variable                                         Whites (n=176)            Non-Whites  (n=25)                     P-value 
Clinic SBP                                      118.5 (12.37)                  121 (10.37)                                     .34 
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Clinic DBP                                     75.52 (7.20)                    78.76 (9.29)                                     .1 
Daytime SBP                                136.7 (14.73)                 131.7 (16.68)                                   .12 
Daytime DBP                                76.22 (7.1)                     79.09 (8.79)                                     .07 
Nighttime SBP                              119.4 (17.3)                  115.9 (15.21)                                   .35 
Nighttime DBP                             62.97 (8.3)                     64.5 (8.68)                                        .4 
 
Table 20: Clinic and ABP by Hypertensive Status 
Variable                                 Hypertensive (n=66)           Normotensive  (n=135)                    P-value 
Clinic SBP                                    122.2 (15.20)               117.1 (9.97)                                        .02 
Clinic DBP                                    77.24 (8.95)                   75.27 (6.68)                                     .08 
Daytime SBP                               137.9 (16.04)               135.9 (14.5)                                       .28 
Daytime DBP                              77.56 (7.56)                   76.10 (7.27)                                     .19 
Nighttime SBP                            120.8 (18.97)                118 (16.04)                                       .28 
Nighttime DBP                           64.15 (9.78)                   62.67 (7.82)                                     .26 
 
 
 
 
 
 
 
 
Table 21: Covariates Predicting Carotid IMT 
Covariates F-value P-value 
Age 16.24 .0001 
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Sex* 14.12 .0002 
Race** .72 .4 
Waist 
circumference*** 
5.10 .03 
Clinic SBP**** .54 .47 
Clinic DBP**** .28 .59 
*controlling for age 
**controlling for age, sex,  
***controlling for age, sex, race 
****controlling for age, sex, race, waist circumference 
 
 
Table 22: Carotid IMT Values  for Total Sample, by Gender, Race, Medication Status, and Age 
Variable                                  Mean (SD)                            Range                                        P-value 
Total Sample  (n=201)              0.88  (.21)                       0.56 – 1.72    
Males (n=101)                           0.94 (.21)                         0.63 – 1.63                                    .0001 
Females (n=100)                       0.82 (.2)                           0.56 – 1.72 
Whites (n=176)                         0.88 (.21)                         0.57 – 1.72                                    .12 
Non-Whites (n=25)                  0.82 (.20)                          0.56 – 1.32 
Hypertensive  (n=66)              0.93 (.22)                           0.59 – 1.45                                    .03 
Normotensive (n=135)           0.86 (.2)                             0.56 – 1.72   
Younger  (<66.95 yrs)              0.81 (.23)                            0.56 – 1.72                                   .0001 
Older (>66.95 yrs)                    0.94 (.16)                            0.56 – 1.40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TTt
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Table 23: Physical Activity Values for the Entire Sample (n=201) 
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Variable                    Mean (SD)                                            Median                                              Range 
 
Min/week                      118.67 (119.42)                                 77.19                                             0 - 760 
METS                              4.92 (1.48)                                                                                                 0 - 10 
# of activities                 1.7                                                                                                              0 - 5 
 
 
Table 24: Within Person results for Physical Activity and Daytime SBP (n=201) 
PA device 1 minute 5 minute 10 minutes 15 minutes 
Wrist T=6.51, p<.0001 T=6.71, p<.0001 T=6.22, p<.0001 T=5.80, p<.0001 
Waist T=3.44, p=.0007 T=7.74, p<.0001 T=5.91, p<.0001 T=5.56, p<.0001 
Self-Report NA NA T=3.54, p<.001 NA 
  
Table 25: Within Person Results for Physical Activity and Daytime DBP (n=201) 
PA device 1 minute 5 minute 10 minutes 15 minutes 
Wrist T=7.47, p<.0001 T=8.69, p<.0001 T=8.93, p<.0001 T=9.42, p<.0001 
Waist T=4.54, p<.0001 T=7.17, p<.0001 T=6.09, p<.0001 T=7.34, p<.0001 
Self-Report NA NA T=3.31 p<.001 NA 
 
Table 26: Within Person Results for Combined Wrist and Waist and Daytime SBP (n=201) 
PA device 1 minute 5 minute 10 minutes 15 minutes 
Wrist Waist T=5.96, 
p<.001 
T=.39, 
p=.69 
T=3.55, 
p=.0005 
T=5.42, 
p<.0001 
T=4.16, 
p<.0001 
T=3.25, 
p=.0013 
T=3.90, 
p=.0003 
T=3.06, 
p=.0026 
 
Table 27: Within Person Results for Combined Wrist and Waist and Daytime DBP (n=201) 
PA device 1 minute 5 minute 10 minutes 15 minutes 
Wrist Waist T=6.93, 
p<.0001 
T=1.32, 
p=.19 
T=6.34, 
p<.0001 
T=3.14, 
p<.002 
T=7.33, 
p<.0001 
T=2.21, 
p=.03 
T=7.12, 
p<.0001 
T=3.15, 
p=.0019 
 
 
 
51
Table 28: Results for 10 minute Waist, Wrist, and Self Report for Daytime SBP (n=201) 
10 min PA measure T-Value P-Value 
Wrist 4.04 .0001 
Waist 2.65 .009 
Self-Report 2.06 .04 
 
Table 29: Results for 10 minute Waist, Wrist, and Self Report for Daytime DBP (n=201) 
10 min PA measure T-Value P-Value 
Wrist 7.33 .0001 
Waist 1.91 .06 
Self-Report 1.26 .21 
 
Table 30: Between Person Results for Physical Activity and Daytime SBP (n=201) 
PA device 1 minute 5 minute 10 minutes 15 minutes 
Wrist F=14.66, p=.0002,  F=.48, p=.49 F=.24, p=.62 F=.55, p=.46 
Waist F=2.39, p=.12 F=4.52, p=.03, 
f²=.02 
F=5.21, p=.02, 
f²=.03 
F=4.10, p=.04, 
f²=.02 
Self-Report NA NA F=38, p=.58 NA 
  
Table 31: Combination of Time Intervals of Waist Accelerometer on Daytime SBP (n=201) 
PA Time Intervals F-value P-value 
5 & 10 minutes 2.60 .08 
5 & 15 minutes 2.40 .09 
10 & 15 minutes 2.97 .05 
5, 10, & 15 minutes 2.73 .04 
 
Table 32: Regression Results of 1 minute wrist and 10 minute waist on Daytime SBP (n=201) 
PA Device F-value P-value 
1 minute wrist 14.97 .0001 
10 minute waist 5.27 .02 
 
Table 33: Between Person Results for Physical Activity and Daytime DBP (n=201) 
PA device 1 minute 5 minute 10 minutes 15 minutes 
Wrist F=4.05, p=.05 F=.43, p=.51 F=.19, p=.85 F=.0, p=.97 
Waist F=.40, p=.53 F=.40, p=.53 F=.03, p=.87 F=.01, p=.94 
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Self-Report NA NA F=1.17, p=.28 NA 
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